Our Mission
We improve human life with Artificial Intelligence
We improve human life with Artificial Intelligence
Infervision is a leading AI medical technology company founded in 2016. Focused on improving multi-disciplinary services and operations with AI, Infervision assists healthcare providers in three key areas: disease screening and diagnosis, patient treatment and management, and research and development.
Adopting a vertical and horizontal product strategy, Infervision offers a comprehensive range of AI-powered software to detect a wide range of anomalies, including cancers, infectious diseases, cardiovascular diseases, cerebrovascular diseases, and trauma. Alongside its existing disease screening and diagnosis (InferRead®), intervention and treatment (InferOperate®), patient health management (InferCare®), and teaching and research initiatives (InferScholar®, InferMartrix, InferEducate), Infervision is a trusted partner for hospitals, other medical institutions, governments, physicians, and patients worldwide.
Infervision's Global Position
•Established in 2016.
•It has 400+ employees.
•It is actively used in 1000+ hospitals.
•Operates in 25 countries. (As of October 2023)
•Received regulatory approvals in China, US, EU, UK and Japan.
•Recognized as the Global AI Healthcare Leader.